Clinical Trial Update: DC Vaccine Combined With CIK Cells in Patients With Renal Cell Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

This is a clinical trial update on a dendritic cell vaccine combined with cytokine-induced killer cells in renal cell carcinoma (Phase 1 and Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• CIK Cells
• DC Vaccine

Snippet

Sponsor: Affiliated Hospital to Academy of Military Medical Sciences | Conditions: Renal Cell Carcinoma | Phase 1, Phase 2 | Status: UNKNOWN